Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Cogent Biosciences (COGT) Revenue (2017 - 2020)

Cogent Biosciences has reported Revenue over the past 4 years, most recently at $312000.0 for Q3 2020.

  • Quarterly results put Revenue at $312000.0 for Q3 2020, down 69.41% from a year ago — trailing twelve months through Jun 2021 was $312000.0 (down 98.69% YoY), and the annual figure for FY2025 was -$3.1 million, changed.
  • Revenue for Q3 2020 was $312000.0 at Cogent Biosciences, down from $528000.0 in the prior quarter.
  • Over the last five years, Revenue for COGT hit a ceiling of $15.3 million in Q4 2019 and a floor of $312000.0 in Q3 2020.
  • Median Revenue over the past 4 years was $2.1 million (2017), compared with a mean of $3.2 million.
  • Biggest five-year swings in Revenue: soared 301.79% in 2019 and later tumbled 83.17% in 2020.
  • Cogent Biosciences' Revenue stood at $2.1 million in 2017, then soared by 79.23% to $3.8 million in 2018, then soared by 301.79% to $15.3 million in 2019, then tumbled by 97.96% to $312000.0 in 2020.
  • The last three reported values for Revenue were $312000.0 (Q3 2020), $528000.0 (Q2 2020), and $7.0 million (Q1 2020) per Business Quant data.